Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Br-DAPI: DAPI Fluorescent Dye for DNA Imaging
2026-08-26
Br-DAPI is a DAPI fluorescent dye and DNA quantification dye that binds A/T-rich regions in double-stranded DNA and increases fluorescence after binding. Its membrane permeability supports live cell DNA staining and fixed cell DNA staining, while careful controls are required to distinguish DNA signal from apoptosis or ER-stress biology.
-
HNRNPU K181 Lactylation in Cervical Cancer
2026-08-26
This Advanced Science study identifies HNRNPU lysine 181 lactylation as a non-histone regulatory mechanism that connects lactate accumulation with PHGDH-dependent serine biosynthesis in cervical cancer. The findings link a post-translational modification switch to RNA stability, redox balance, nucleotide production, tumor growth, and a pharmacological response to Pazopanib.
-
TMEM16F Scrambling Links Ferroptosis to Tumor Immunity
2026-08-25
Yang et al. identify TMEM16F-mediated plasma-membrane phospholipid scrambling as a late-stage suppressor of ferroptotic membrane failure. The study further shows that disabling this repair-like response promotes lytic death, danger-signal release, slower tumor growth, and stronger responses to PD-1 blockade in preclinical models.
-
Hesperadin: Aurora B Kinase Workflow Guide
2026-08-24
Hesperadin is an ATP-competitive Aurora B kinase inhibitor for dissecting histone H3 phosphorylation, chromosome segregation, cytokinesis, and polyploidization. This practical guide combines cell-based workflows with checkpoint-complex controls so researchers can distinguish Aurora-driven phenotypes from direct effects on MCC disassembly.
-
Fluoxetine HCl: Mechanism and Research Workflows
2026-08-24
Fluoxetine HCl is a selective serotonin reuptake inhibitor used to interrogate serotonin transport, 5-HT2C signaling, neurogenesis, and reward-related behavior. Its acute molecular effects should be separated from developmental SSRI exposure, which is associated with persistent motivational phenotypes in preclinical models.
-
REV1–DHX36 Control of G-Quadruplex Replication
2026-08-23
A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings establish a two-tier mechanism for G4 tolerance and connect REV1 deficiency with increased ATM/ATR signaling and sensitivity to G4-stabilizing agents.
-
PR-619 for DUB Inhibition Workflows
2026-08-22
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor for separating DUB-dependent ubiquitin accumulation from direct proteasome blockade. This guide translates its chemistry into practical workflows for ubiquitination pathway research, autophagy assays, cancer biology, and carefully bounded immuno-oncology experiments.
-
CMA Decline, SERCA Dysfunction, and Age-Related Myopathy
2026-08-21
This Nature Metabolism study establishes chaperone-mediated autophagy (CMA) as an active regulator of skeletal muscle maintenance rather than a passive lysosomal pathway. Using reporter, genetic, proteomic, physiological, and human-tissue analyses, the authors connect age-related CMA loss to impaired SERCA turnover, calcium dysregulation, muscle weakness, and progressive myopathy.
-
MG-132 (Z-LLL-al) in LUAD Proteasome Workflows
2026-08-20
MG-132 (Z-LLL-al) provides an acute, cell-permeable way to test whether proteasome-dependent protein turnover contributes to LUAD phenotypes. This workflow-focused guide connects PSMA4–p53 biology with apoptosis assays, cell cycle arrest studies, ROS measurements, and practical troubleshooting.
-
RQ3025: Broad-Spectrum mRNA Vaccine Preclinical Study
2026-08-20
This 2024 preclinical study evaluates RQ3025, a bivalent mRNA vaccine designed around conserved and variant-associated SARS-CoV-2 spike mutations. Across mice, hamsters, and rats, the vaccine generated broad neutralizing activity, protected rats from several variants, induced a Th1-biased response, and showed no apparent organ pathology in a high-dose safety assessment.
-
Sodium Ascorbate Workflows for Cancer Research
2026-08-19
Sodium Ascorbate provides a practical ROS-focused intervention for glioblastoma, prostate cancer, and broader tumor-cell assays. This guide connects solvent handling, viability and motility workflows, and immune-biomarker stratification while clearly separating established product evidence from exploratory applications.
-
S1P/S1PR3 Drives Neuronal Apoptosis After ICH
2026-08-19
The reference study identifies an S1P–S1PR3 axis that links post-hemorrhagic inflammation with neuronal apoptosis through TNF-α, PI3K/AKT-associated signaling, and cleaved caspase-3. Its mouse and HT22-cell experiments position S1PR3 as a mechanistic and potentially targetable component of secondary brain injury after intracerebral hemorrhage.
-
Dorsomorphin 2HCl: From AMPK Probe to Translation
2026-08-18
Dorsomorphin 2HCl is more than a routine AMPK inhibitor: it is a pharmacological stress test for causal metabolism research. This thought-leadership guide connects the compound’s AMPK and BMP activity with hepatic steatosis, osteogenesis, hepcidin expression regulation, formulation strategy, and translational decision-making.
-
Cy5 Hydrazide for Carbonyl Labeling
2026-08-18
Cy5 hydrazide provides a far-red strategy for protein carbonylation labeling, glycoprotein analysis, and aldehyde/ketone biomolecule labeling. This article explains how to use its chemistry as an analytical bridge for validating oxidative stress and nanoparticle–cell interaction studies.
-
Ionic Polyphosphazene–Protein Formulations
2026-08-17
Andrianov and colleagues developed soluble and nanoparticulate ionic polyphosphazene systems that assemble with lysozyme near physiological pH, with spermine-mediated cross-linking used to tune formulation behavior. The study shows that nanoparticle architecture, rather than protein integrity alone, strongly influences cellular enzyme presentation and activity.